SlideShare ist ein Scribd-Unternehmen logo
1 von 16
Downloaden Sie, um offline zu lesen
Agricultural biotechnology in
Europe: benefits and issues


       20 September 2005
        Graham Brookes
          PG Economics
Presentation coverage

Current status of agricultural biotechnology use in
Europe
Why do farmers use the technology?
Issues affecting current adoption
Implications of ignoring agricultural biotechnology in
Europe
Copies of various research papers on these issues
available on www.pgeconomics.co.uk
Biotech crop plantings Europe
         Country                 Crop            2004-05 (hectares)        Comments
Spain                      IR Grain maize          58,100 (2004)         48,000 ha 2005
                                                                          (decrease due to
                                                                           drought: fall in
                                                                             total maize
                                                                              plantings)
Portugal                   IR Grain maize           780 (2005)            1st year 2005
Germany                    IR Grain maize         300-500 (2005)      Pre-commercialisation
                                                                              only

Czech Republic             IR Grain maize           300 (2005)            1st year 2005
France                     IR Grain maize           500 (2005)

Romania                     HT Soybeans            70,000 (2004)

IR = insect resistant, HT = herbicide tolerant
Main commercial biotech crops: 2004

Insect resistant (IR) maize in Spain:
since 1998
Herbicide tolerant (HT) soy in Romania:
since 1999
2004: 58,000 ha Spain (12% of crop),
70,000 ha Romania (58% of crop)
Why do farmers use the technology:
     GM IR maize in Spain?
GM IR maize targets main corn pest in Spain
(corn borer) – causes economic damage to
25-30% of crop area
Corn borer incidence varies by region and
year – affected by climate/weather and
planting times
GM IR corn in Spain 2004
Why do farmers use the technology:
  GM HT soybeans in Romania
Addresses weed problems effectively
Weeds = main problem affecting yields and
harvest quality
Problem linked to limited herbicide use since
1990 – economic difficulties - establishment of
weeds difficult to control
Few farmers apply full recommended number
of sprays (low profitability)
Farm level of GM crops in Europe
                          Average      Range


Spain: yield impact       +6.3%     +1% to +15%

Romania: yield impact      +31%     +12% to +50%

Spain: increase in farm    +13%     Zero to +29%
gross margin

Romania: increase in      +156%     +12% to +300%
gross margin
National level impact of GM crop use

Million Euros     2004    Cumulative     Value added as
                           since first   % of national
                             grown        production
                                          value 2004

IR maize: Spain   +5.2       +18              +1


HT soy:           +14.8      +31.4            +25
Romania
Other impacts
Insurance benefit: a production risk management
tool
Convenience benefit: less time crop walking/spraying
Small saving in energy costs and fuel
Improved quality (lower mycotoxin levels in corn,
less weed material in soy)
Reduced risk of exposure to agro-chemicals
Environmental benefits: lower levels of spraying
and/or switch to more environmentally benign
herbicides
Conclusion on farm level impact
Benefit varies with level of pest & weed problems = varies by
region and year
Offers substantial benefits to some farmers but of marginal
benefit to others = not a technology for all farmers
Main benefits to the farmer; higher yield, improved farm
profitability, convenience, risk management and less exposure
to pesticides
Main benefits to society: contribution to lower costs/real
prices, improved grain quality (less mycotoxins) and improved
environmental ‘foot print’ (less spraying)
Why limited adoption in Europe?
Lack of trait approval for planting: only GM IR (bt)
maize so far approved & few traits now being bought
forward for reg approval
Conditions of use: so-called co-existence measures
Opposition to technology: NGOs very active &
effective in scaring farmers, food chain, politicians
and consumers
Farmers will only adopt if they perceive can sell their
crops
Development of non GM market
Why limited use in Europe: co-
             existence
Co-existence rules: supposed to allow farmers
freedom to choose method of production
In Spain have been based on sound science &
commercial experience BUT some political
interference from 2006
Being used in some countries as a way to
discourage adoption (eg, Portugal, Germany)
Why limited use in Europe: non GM
             demand
Demand for non GM products: perception that
this dominates = influences farmer planting
decisions
BUT
Reality: only 15% of soy and 25% corn
required to be certified as non GM in Europe
What is Europe missing out on?
Economic benefits = important for competitiveness
of agriculture & food industry in Europe – competes
in an ever ‘open’ global market
Failure to adopt cost saving & productivity enhancing
technology = loss of income & employment in
European agriculture & user sectors
Loss of environmental benefits: decreased
environmental footprint from pesticide use &
contribution to lower greenhouse gas emissions
The future

Ag biotech likely to be embraced slowly in
Europe
Currently-next 5 years: Europe loses out
economically & environmentally
Wider adoption will come 5-10 year horizon
but playing catch up with rest of world

Weitere ähnliche Inhalte

Ähnlich wie monsanto 09-20-05

Scotland_the future of the CAP
Scotland_the future of the CAPScotland_the future of the CAP
Scotland_the future of the CAP
allysun
 
Richard Young - True Cost Accounting in Food and Agricultural Policy
Richard Young - True Cost Accounting in Food and Agricultural PolicyRichard Young - True Cost Accounting in Food and Agricultural Policy
Richard Young - True Cost Accounting in Food and Agricultural Policy
Sustainable Food Trust
 

Ähnlich wie monsanto 09-20-05 (20)

Setting the scene_Nathalie Bolduc.pdf
Setting the scene_Nathalie Bolduc.pdfSetting the scene_Nathalie Bolduc.pdf
Setting the scene_Nathalie Bolduc.pdf
 
Bio Fuel for Aviation
Bio Fuel for AviationBio Fuel for Aviation
Bio Fuel for Aviation
 
Rural Network for improvement and dissemination of soil conservation systems ...
Rural Network for improvement and dissemination of soil conservation systems ...Rural Network for improvement and dissemination of soil conservation systems ...
Rural Network for improvement and dissemination of soil conservation systems ...
 
Scotland_the future of the CAP
Scotland_the future of the CAPScotland_the future of the CAP
Scotland_the future of the CAP
 
The Latin America Context: emissions, projections and mitigation plans
The Latin America Context: emissions, projections and mitigation plansThe Latin America Context: emissions, projections and mitigation plans
The Latin America Context: emissions, projections and mitigation plans
 
Richard Young - True Cost Accounting in Food and Agricultural Policy
Richard Young - True Cost Accounting in Food and Agricultural PolicyRichard Young - True Cost Accounting in Food and Agricultural Policy
Richard Young - True Cost Accounting in Food and Agricultural Policy
 
Harriet Bradley
Harriet BradleyHarriet Bradley
Harriet Bradley
 
Gamal Siam (Cairo University) • 2021 IFPRI Egypt Seminar Series: "COVID-19 le...
Gamal Siam (Cairo University) • 2021 IFPRI Egypt Seminar Series: "COVID-19 le...Gamal Siam (Cairo University) • 2021 IFPRI Egypt Seminar Series: "COVID-19 le...
Gamal Siam (Cairo University) • 2021 IFPRI Egypt Seminar Series: "COVID-19 le...
 
Cultivos Genéticamente Modificados
Cultivos Genéticamente ModificadosCultivos Genéticamente Modificados
Cultivos Genéticamente Modificados
 
Australian public policy to mitigate and adapt agriculture for climate change...
Australian public policy to mitigate and adapt agriculture for climate change...Australian public policy to mitigate and adapt agriculture for climate change...
Australian public policy to mitigate and adapt agriculture for climate change...
 
1b_Eu view nutrient management.pptx
1b_Eu view nutrient management.pptx1b_Eu view nutrient management.pptx
1b_Eu view nutrient management.pptx
 
Rhone-Alpes Fransa
Rhone-Alpes FransaRhone-Alpes Fransa
Rhone-Alpes Fransa
 
Can agricultural biotechnologies address the challenges of climate change. li...
Can agricultural biotechnologies address the challenges of climate change. li...Can agricultural biotechnologies address the challenges of climate change. li...
Can agricultural biotechnologies address the challenges of climate change. li...
 
GM crops for reducing greenhouse gas emissions - Rick Roush
GM crops for reducing greenhouse gas emissions - Rick RoushGM crops for reducing greenhouse gas emissions - Rick Roush
GM crops for reducing greenhouse gas emissions - Rick Roush
 
A Thriving Agriculture Sector in a Changing Climate: A Global Perspective for...
A Thriving Agriculture Sector in a Changing Climate: A Global Perspective for...A Thriving Agriculture Sector in a Changing Climate: A Global Perspective for...
A Thriving Agriculture Sector in a Changing Climate: A Global Perspective for...
 
Day1_Theme6_Will Martin
Day1_Theme6_Will MartinDay1_Theme6_Will Martin
Day1_Theme6_Will Martin
 
Agro exports potential
Agro exports potentialAgro exports potential
Agro exports potential
 
E Gonzalez
E GonzalezE Gonzalez
E Gonzalez
 
Climate smart agriculture and its benefits for ecosystems and food security 2...
Climate smart agriculture and its benefits for ecosystems and food security 2...Climate smart agriculture and its benefits for ecosystems and food security 2...
Climate smart agriculture and its benefits for ecosystems and food security 2...
 
BSB908_Virtual Infoday__BAA.pdf
BSB908_Virtual Infoday__BAA.pdfBSB908_Virtual Infoday__BAA.pdf
BSB908_Virtual Infoday__BAA.pdf
 

Mehr von finance28

virgin media.FINAL_Q4_06_Presentation_VMED
virgin media.FINAL_Q4_06_Presentation_VMEDvirgin media.FINAL_Q4_06_Presentation_VMED
virgin media.FINAL_Q4_06_Presentation_VMED
finance28
 
virgin media.FINAL_Q4_06_Presentation_VMED
virgin media.FINAL_Q4_06_Presentation_VMEDvirgin media.FINAL_Q4_06_Presentation_VMED
virgin media.FINAL_Q4_06_Presentation_VMED
finance28
 
virgin media.Q1_07_Analyst_presentation_FINAL
virgin media.Q1_07_Analyst_presentation_FINALvirgin media.Q1_07_Analyst_presentation_FINAL
virgin media.Q1_07_Analyst_presentation_FINAL
finance28
 
virgin media.Q1_07_Analyst_presentation_FINAL
virgin media.Q1_07_Analyst_presentation_FINALvirgin media.Q1_07_Analyst_presentation_FINAL
virgin media.Q1_07_Analyst_presentation_FINAL
finance28
 
virgin media.Q2-07_Analyst_presentation
virgin media.Q2-07_Analyst_presentationvirgin media.Q2-07_Analyst_presentation
virgin media.Q2-07_Analyst_presentation
finance28
 
virgin media.Q2-07_Analyst_presentation
virgin media.Q2-07_Analyst_presentationvirgin media.Q2-07_Analyst_presentation
virgin media.Q2-07_Analyst_presentation
finance28
 
virgin media.Q3_07_AnalystPresentation
virgin media.Q3_07_AnalystPresentationvirgin media.Q3_07_AnalystPresentation
virgin media.Q3_07_AnalystPresentation
finance28
 
virgin media.Q3_07_AnalystPresentation
virgin media.Q3_07_AnalystPresentationvirgin media.Q3_07_AnalystPresentation
virgin media.Q3_07_AnalystPresentation
finance28
 
virgin media.UBS_vmed_December07_FINAL
virgin media.UBS_vmed_December07_FINALvirgin media.UBS_vmed_December07_FINAL
virgin media.UBS_vmed_December07_FINAL
finance28
 
virgin media.UBS_vmed_December07_FINAL
virgin media.UBS_vmed_December07_FINALvirgin media.UBS_vmed_December07_FINAL
virgin media.UBS_vmed_December07_FINAL
finance28
 
virgin media._Q12008_presentation
virgin media._Q12008_presentationvirgin media._Q12008_presentation
virgin media._Q12008_presentation
finance28
 
virgin media.VMED_Q12008_presentation
virgin media.VMED_Q12008_presentationvirgin media.VMED_Q12008_presentation
virgin media.VMED_Q12008_presentation
finance28
 
virgin media.FINAL_Q208_Presentation
virgin media.FINAL_Q208_Presentationvirgin media.FINAL_Q208_Presentation
virgin media.FINAL_Q208_Presentation
finance28
 
virgin media.FINAL_Q208_Presentation
virgin media.FINAL_Q208_Presentationvirgin media.FINAL_Q208_Presentation
virgin media.FINAL_Q208_Presentation
finance28
 
virgin media.Q3_08_Presentation
virgin media.Q3_08_Presentationvirgin media.Q3_08_Presentation
virgin media.Q3_08_Presentation
finance28
 
virgin media.Q3_08_Presentation
virgin media.Q3_08_Presentationvirgin media.Q3_08_Presentation
virgin media.Q3_08_Presentation
finance28
 
virgin media.Analyst_day_november112008
virgin media.Analyst_day_november112008virgin media.Analyst_day_november112008
virgin media.Analyst_day_november112008
finance28
 
virgin media.Analyst_day_november112008
virgin media.Analyst_day_november112008virgin media.Analyst_day_november112008
virgin media.Analyst_day_november112008
finance28
 
virgin media.london_nov132008
virgin media.london_nov132008virgin media.london_nov132008
virgin media.london_nov132008
finance28
 
virgin media.london_nov132008
virgin media.london_nov132008virgin media.london_nov132008
virgin media.london_nov132008
finance28
 

Mehr von finance28 (20)

virgin media.FINAL_Q4_06_Presentation_VMED
virgin media.FINAL_Q4_06_Presentation_VMEDvirgin media.FINAL_Q4_06_Presentation_VMED
virgin media.FINAL_Q4_06_Presentation_VMED
 
virgin media.FINAL_Q4_06_Presentation_VMED
virgin media.FINAL_Q4_06_Presentation_VMEDvirgin media.FINAL_Q4_06_Presentation_VMED
virgin media.FINAL_Q4_06_Presentation_VMED
 
virgin media.Q1_07_Analyst_presentation_FINAL
virgin media.Q1_07_Analyst_presentation_FINALvirgin media.Q1_07_Analyst_presentation_FINAL
virgin media.Q1_07_Analyst_presentation_FINAL
 
virgin media.Q1_07_Analyst_presentation_FINAL
virgin media.Q1_07_Analyst_presentation_FINALvirgin media.Q1_07_Analyst_presentation_FINAL
virgin media.Q1_07_Analyst_presentation_FINAL
 
virgin media.Q2-07_Analyst_presentation
virgin media.Q2-07_Analyst_presentationvirgin media.Q2-07_Analyst_presentation
virgin media.Q2-07_Analyst_presentation
 
virgin media.Q2-07_Analyst_presentation
virgin media.Q2-07_Analyst_presentationvirgin media.Q2-07_Analyst_presentation
virgin media.Q2-07_Analyst_presentation
 
virgin media.Q3_07_AnalystPresentation
virgin media.Q3_07_AnalystPresentationvirgin media.Q3_07_AnalystPresentation
virgin media.Q3_07_AnalystPresentation
 
virgin media.Q3_07_AnalystPresentation
virgin media.Q3_07_AnalystPresentationvirgin media.Q3_07_AnalystPresentation
virgin media.Q3_07_AnalystPresentation
 
virgin media.UBS_vmed_December07_FINAL
virgin media.UBS_vmed_December07_FINALvirgin media.UBS_vmed_December07_FINAL
virgin media.UBS_vmed_December07_FINAL
 
virgin media.UBS_vmed_December07_FINAL
virgin media.UBS_vmed_December07_FINALvirgin media.UBS_vmed_December07_FINAL
virgin media.UBS_vmed_December07_FINAL
 
virgin media._Q12008_presentation
virgin media._Q12008_presentationvirgin media._Q12008_presentation
virgin media._Q12008_presentation
 
virgin media.VMED_Q12008_presentation
virgin media.VMED_Q12008_presentationvirgin media.VMED_Q12008_presentation
virgin media.VMED_Q12008_presentation
 
virgin media.FINAL_Q208_Presentation
virgin media.FINAL_Q208_Presentationvirgin media.FINAL_Q208_Presentation
virgin media.FINAL_Q208_Presentation
 
virgin media.FINAL_Q208_Presentation
virgin media.FINAL_Q208_Presentationvirgin media.FINAL_Q208_Presentation
virgin media.FINAL_Q208_Presentation
 
virgin media.Q3_08_Presentation
virgin media.Q3_08_Presentationvirgin media.Q3_08_Presentation
virgin media.Q3_08_Presentation
 
virgin media.Q3_08_Presentation
virgin media.Q3_08_Presentationvirgin media.Q3_08_Presentation
virgin media.Q3_08_Presentation
 
virgin media.Analyst_day_november112008
virgin media.Analyst_day_november112008virgin media.Analyst_day_november112008
virgin media.Analyst_day_november112008
 
virgin media.Analyst_day_november112008
virgin media.Analyst_day_november112008virgin media.Analyst_day_november112008
virgin media.Analyst_day_november112008
 
virgin media.london_nov132008
virgin media.london_nov132008virgin media.london_nov132008
virgin media.london_nov132008
 
virgin media.london_nov132008
virgin media.london_nov132008virgin media.london_nov132008
virgin media.london_nov132008
 

Kürzlich hochgeladen

abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammamabortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
samsungultra782445
 
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdfFOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
Cocity Enterprises
 
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdfMASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
Cocity Enterprises
 

Kürzlich hochgeladen (20)

cost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptxcost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptx
 
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
 
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammamabortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
 
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai MultipleDubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
 
Webinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech BelgiumWebinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech Belgium
 
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
 
Group 8 - Goldman Sachs & 1MDB Case Studies
Group 8 - Goldman Sachs & 1MDB Case StudiesGroup 8 - Goldman Sachs & 1MDB Case Studies
Group 8 - Goldman Sachs & 1MDB Case Studies
 
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
 
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
 
Seeman_Fiintouch_LLP_Newsletter_May-2024.pdf
Seeman_Fiintouch_LLP_Newsletter_May-2024.pdfSeeman_Fiintouch_LLP_Newsletter_May-2024.pdf
Seeman_Fiintouch_LLP_Newsletter_May-2024.pdf
 
Pension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdfPension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdf
 
Strategic Resources May 2024 Corporate Presentation
Strategic Resources May 2024 Corporate PresentationStrategic Resources May 2024 Corporate Presentation
Strategic Resources May 2024 Corporate Presentation
 
falcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunitiesfalcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunities
 
Collecting banker, Capacity of collecting Banker, conditions under section 13...
Collecting banker, Capacity of collecting Banker, conditions under section 13...Collecting banker, Capacity of collecting Banker, conditions under section 13...
Collecting banker, Capacity of collecting Banker, conditions under section 13...
 
7 tips trading Deriv Accumulator Options
7 tips trading Deriv Accumulator Options7 tips trading Deriv Accumulator Options
7 tips trading Deriv Accumulator Options
 
Explore Dual Citizenship in Africa | Citizenship Benefits & Requirements
Explore Dual Citizenship in Africa | Citizenship Benefits & RequirementsExplore Dual Citizenship in Africa | Citizenship Benefits & Requirements
Explore Dual Citizenship in Africa | Citizenship Benefits & Requirements
 
fundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docxfundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docx
 
劳伦森大学毕业证
劳伦森大学毕业证劳伦森大学毕业证
劳伦森大学毕业证
 
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdfFOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
 
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdfMASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
 

monsanto 09-20-05

  • 1. Agricultural biotechnology in Europe: benefits and issues 20 September 2005 Graham Brookes PG Economics
  • 2. Presentation coverage Current status of agricultural biotechnology use in Europe Why do farmers use the technology? Issues affecting current adoption Implications of ignoring agricultural biotechnology in Europe Copies of various research papers on these issues available on www.pgeconomics.co.uk
  • 3. Biotech crop plantings Europe Country Crop 2004-05 (hectares) Comments Spain IR Grain maize 58,100 (2004) 48,000 ha 2005 (decrease due to drought: fall in total maize plantings) Portugal IR Grain maize 780 (2005) 1st year 2005 Germany IR Grain maize 300-500 (2005) Pre-commercialisation only Czech Republic IR Grain maize 300 (2005) 1st year 2005 France IR Grain maize 500 (2005) Romania HT Soybeans 70,000 (2004) IR = insect resistant, HT = herbicide tolerant
  • 4. Main commercial biotech crops: 2004 Insect resistant (IR) maize in Spain: since 1998 Herbicide tolerant (HT) soy in Romania: since 1999 2004: 58,000 ha Spain (12% of crop), 70,000 ha Romania (58% of crop)
  • 5. Why do farmers use the technology: GM IR maize in Spain? GM IR maize targets main corn pest in Spain (corn borer) – causes economic damage to 25-30% of crop area Corn borer incidence varies by region and year – affected by climate/weather and planting times
  • 6. GM IR corn in Spain 2004
  • 7. Why do farmers use the technology: GM HT soybeans in Romania Addresses weed problems effectively Weeds = main problem affecting yields and harvest quality Problem linked to limited herbicide use since 1990 – economic difficulties - establishment of weeds difficult to control Few farmers apply full recommended number of sprays (low profitability)
  • 8. Farm level of GM crops in Europe Average Range Spain: yield impact +6.3% +1% to +15% Romania: yield impact +31% +12% to +50% Spain: increase in farm +13% Zero to +29% gross margin Romania: increase in +156% +12% to +300% gross margin
  • 9. National level impact of GM crop use Million Euros 2004 Cumulative Value added as since first % of national grown production value 2004 IR maize: Spain +5.2 +18 +1 HT soy: +14.8 +31.4 +25 Romania
  • 10. Other impacts Insurance benefit: a production risk management tool Convenience benefit: less time crop walking/spraying Small saving in energy costs and fuel Improved quality (lower mycotoxin levels in corn, less weed material in soy) Reduced risk of exposure to agro-chemicals Environmental benefits: lower levels of spraying and/or switch to more environmentally benign herbicides
  • 11. Conclusion on farm level impact Benefit varies with level of pest & weed problems = varies by region and year Offers substantial benefits to some farmers but of marginal benefit to others = not a technology for all farmers Main benefits to the farmer; higher yield, improved farm profitability, convenience, risk management and less exposure to pesticides Main benefits to society: contribution to lower costs/real prices, improved grain quality (less mycotoxins) and improved environmental ‘foot print’ (less spraying)
  • 12. Why limited adoption in Europe? Lack of trait approval for planting: only GM IR (bt) maize so far approved & few traits now being bought forward for reg approval Conditions of use: so-called co-existence measures Opposition to technology: NGOs very active & effective in scaring farmers, food chain, politicians and consumers Farmers will only adopt if they perceive can sell their crops Development of non GM market
  • 13. Why limited use in Europe: co- existence Co-existence rules: supposed to allow farmers freedom to choose method of production In Spain have been based on sound science & commercial experience BUT some political interference from 2006 Being used in some countries as a way to discourage adoption (eg, Portugal, Germany)
  • 14. Why limited use in Europe: non GM demand Demand for non GM products: perception that this dominates = influences farmer planting decisions BUT Reality: only 15% of soy and 25% corn required to be certified as non GM in Europe
  • 15. What is Europe missing out on? Economic benefits = important for competitiveness of agriculture & food industry in Europe – competes in an ever ‘open’ global market Failure to adopt cost saving & productivity enhancing technology = loss of income & employment in European agriculture & user sectors Loss of environmental benefits: decreased environmental footprint from pesticide use & contribution to lower greenhouse gas emissions
  • 16. The future Ag biotech likely to be embraced slowly in Europe Currently-next 5 years: Europe loses out economically & environmentally Wider adoption will come 5-10 year horizon but playing catch up with rest of world